The Himalaya of Medtech: Building a Next-Gen Heart Pump From Scratch with Louis de Lillers

In this episode of the Crux of Cardio, your host Jordan Burgin sits down with Louis de Lillers, CEO of CorWave, the French company developing a next-generation LVAD powered by the wave membrane technology inspired by the motion of marine animals. Louis shares why current LVADs leave patients alive but without a pulse, and how… Continue reading The Himalaya of Medtech: Building a Next-Gen Heart Pump From Scratch with Louis de Lillers

Five Billion-Dollar Deals in 45 Days: Inside the Cardiac Monitoring Gold Rush with Ken Nelson

In this episode of The Crux of Cardio, Jordan Burgin sits down with Ken Nelson, one of the most experienced commercial leaders in cardiac digital health. Ken helped scale commercial teams at iRhythm, BioTelemetry/CardioNet, and Bardy Diagnostics, three of the defining names in ambulatory cardiac monitoring. He shares the inside story behind the 2020–2021 cardiac… Continue reading Five Billion-Dollar Deals in 45 Days: Inside the Cardiac Monitoring Gold Rush with Ken Nelson

Half a Million Patients a Year and No Good Options, Until Now with Dr. Lucy O’Keeffe

In this episode, your host Jordan Burgin sits down with Dr. Lucy O’Keeffe, CEO and Co-Founder of CroíValve, for the first ever in-person recording of the Crux of Cardio. Lucy explains why the tricuspid valve was once considered the “forgotten valve”, how her Dublin-based team is building a device that sits between repair and replacement,… Continue reading Half a Million Patients a Year and No Good Options, Until Now with Dr. Lucy O’Keeffe

The Heart Failure Industry Has It Wrong, This Tiny Turbine Could Fix It with Arnaud Mascarell

In this episode of Crux of Cardio, Jordan Burgin sits down with Arnaud Mascarell, CEO and Co-Founder of FineHeart, the Bordeaux-based company behind the FlowMaker, a fully implantable cardiac assist device that works in synchrony with the heart’s natural contraction rather than replacing it. Arnaud shares the full journey: 18 years at Medtronic pioneering CRT… Continue reading The Heart Failure Industry Has It Wrong, This Tiny Turbine Could Fix It with Arnaud Mascarell

From Territory Manager to CCO of a $400M Cardiovascular Powerhouse with Tarik Paćuka

In this episode of the Crux of Cardio, Jordan Burgin sits down with Tarik Paćuka, former Chief Commercial Officer of Terumo Aortic, who scaled the business from a niche textile graft company into a $400M+ global cardiovascular player. Tarik shares the commercial playbook behind his 15-year rise from territory manager to CCO, the mentorship that… Continue reading From Territory Manager to CCO of a $400M Cardiovascular Powerhouse with Tarik Paćuka

Cardiac Ablation Has A 50% Problem, Here’s The Fix with Andreu Climent

Jordan is joined by Andreu Climent, CEO of Corify Care, a cardiac mapping company using non-invasive, whole-heart technology to guide EP procedures in real time. Andreu brings a telecoms engineering background to a problem most cardiologists have accepted as unsolvable: that half of all AF ablations fail, because clinicians are operating without seeing the full… Continue reading Cardiac Ablation Has A 50% Problem, Here’s The Fix with Andreu Climent

Wall Street Said It Couldn’t Be Done, We Did It Anyway with Wayne Paterson

Wayne Paterson, CEO and Vice Chairman of Anteris Technologies, joins host Jordan Bergen for a frank conversation about pivoting a failing drug company into the structural heart space and building what may be medtech’s next billion-dollar product. Wayne shares how 36 drug launches, a pharma-first lens on total disease management, and a blank sheet of… Continue reading Wall Street Said It Couldn’t Be Done, We Did It Anyway with Wayne Paterson

The Heart Valve Treatment That Doesn’t Touch the Patient with Carine Schorochoff

In this episode, host Jordan Burgin sits down with Carine Schorochoff, CEO of Cardiawave, to explore Valvosoft the world’s first CE-marked non-invasive ultrasound therapy for severe symptomatic aortic stenosis. With 30-plus years in structural heart across J&J, Medtronic, Edwards Lifesciences, and two startup CEO roles, Carine breaks down why the technology has delivered 0% stroke… Continue reading The Heart Valve Treatment That Doesn’t Touch the Patient with Carine Schorochoff